SB-237376 FREE BASE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C20H25N3O5
Molecular Weight	387.4296
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

COC1=C(OC)C=C(CCNCCCNC(=O)C2=CC=C(C=C2)[N+]([O-])=O)C=C1

InChI

InChIKey=XEAKAKKNLOUHDV-UHFFFAOYSA-N

InChI=1S/C20H25N3O5/c1-27-18-9-4-15(14-19(18)28-2)10-13-21-11-3-12-22-20(24)16-5-7-17(8-6-16)23(25)26/h4-9,14,21H,3,10-13H2,1-2H3,(H,22,24)

HIDE SMILES / InChI

Molecular Formula	C20H25N3O5
Molecular Weight	387.4296
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 09:35:16 GMT 2023` Edited by `admin` on `Sat Dec 16 09:35:16 GMT 2023`
Record UNII	JED8M29NSU
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SB-237376 FREE BASE

Common Name

English

BENZAMIDE, N-(3-((2-(3,4-DIMETHOXYPHENYL)ETHYL)AMINO)PROPYL)-4-NITRO-

Systematic Name

English

Code System Code Type Description

PUBCHEM

9845214

Created by admin on Sat Dec 16 09:35:16 GMT 2023 , Edited by admin on Sat Dec 16 09:35:16 GMT 2023

PRIMARY

MANUFACTURER PRODUCT INFORMATION

SB-237376

Created by admin on Sat Dec 16 09:35:16 GMT 2023 , Edited by admin on Sat Dec 16 09:35:16 GMT 2023

PRIMARY

<b>SB 237376</b> was in phase II trials with GlaxoSmithKline in Europe for the treatment of cardiac arrhythmias. However, its development has been discontinued.

CAS

179258-59-4

Created by admin on Sat Dec 16 09:35:16 GMT 2023 , Edited by admin on Sat Dec 16 09:35:16 GMT 2023

PRIMARY

FDA UNII

JED8M29NSU

Created by admin on Sat Dec 16 09:35:16 GMT 2023 , Edited by admin on Sat Dec 16 09:35:16 GMT 2023

PRIMARY

Related Record Type Details